Heart Disease News and Research

Latest Heart Disease News and Research

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced the publication of an overview of lysosomal acid lipase deficiency (LAL Deficiency) in the online version and an upcoming print edition of Atherosclerosis, the official journal of the European Atherosclerosis Society.

21 Apr 2014

MEDNAX acquires Fredericksburg Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of Fredericksburg Anesthesia Associates, Inc., a private practice physician group based in Fredericksburg, Va. The practice will become part of MEDNAX's American Anesthesiology division and is the third Virginia-based anesthesia practice to join the division.

21 Apr 2014

First Edition: April 21, 2014

Today's early morning highlights from the major news organizations, including a GAO report on how the Obama administration raised money from outside groups to promote the health law.

21 Apr 2014

Scientists lay groundwork for understanding immune responses in Lyme disease patients

A team of scientists led by Johns Hopkins and Stanford University researchers has laid the groundwork for understanding how variations in immune responses to Lyme disease can contribute to the many different outcomes of this bacterial infection seen in individual patients. A report on the work appears online April 16 in PLOS One.

21 Apr 2014

Highly advanced imaging method helps to monitor rapid changes in glutathione redox potentials in live cells

In the April issue of Experimental Biology and Medicine a multidisciplinary research team led by Drs. Rex Gaskins and Paul Kenis in the Institute of Genomic Biology (IGB) on the campus of the University of Illinois Urbana-Champaign describe their recent work on subcellular redox homeostasis.

21 Apr 2014

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.

21 Apr 2014

Research roundup: Colonscopy in the countryside; retiree health benefits; what should hip surgery cost?

Rural residents who commonly seek treatment for advanced stages of colorectal cancer have been thought to lack access to cancer screening and adjuvant therapy. ... Several theories have been postulated to explain these findings, some of which include low socioeconomic status, lower educational attainment, lack of insurance coverage, underinsurance, and travel distance to health care facilities.

21 Apr 2014

Researchers receive $3.7M NIH grant to develop anti-smoking program for HIV-infected smoker

Montefiore Medical Center researchers have received a $3.7 million grant from the National Institute on Drug Abuse at the National Institutes of Health (NIH) to develop an anti-smoking program for HIV-infected smokers.

21 Apr 2014

Researchers reveal connection between Down syndrome and acute lymphoblastic leukemia

Although doctors have long known that people with Down syndrome have a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood, they haven't been able to explain why. Now, a team of Dana-Farber Cancer Institute investigators has uncovered a connection between the two conditions.

21 Apr 2014

Longer Looks: HIV epidemic in the Deep South; planning for Alzheimer's; Obamacare conspiracy theory

One of the strangest things about the H.I.V. epidemic in the Deep South - from Louisiana to Alabama to Mississippi - is how easily most Americans have elided it, choosing instead to imagine that the disease is now an out-there, elsewhere epidemic.

18 Apr 2014

Le Bonheur Children's takes aggressive steps to minimize blood loss during heart surgery

More than 20 percent of Le Bonheur Children's Hospital's open heart surgeries are now bloodless, meaning no blood or blood products given during surgery. The Memphis, Tenn., hospital's Heart Institute has been taking aggressive steps to minimize blood loss during surgery and reduce perioperative blood transfusions over the last 18 months.

18 Apr 2014

Scientist receives $1.8M defense grant from Kessler Foundation for spinal cord injury research

Kessler Foundation has been named awardee of a three-year grant for $1.8 million from the Department of Defense Spinal Cord Injury Research Program. Gail Forrest, PT, PhD, is principal investigator for the randomized, double-blinded, controlled, multi-site clinical trial, which will test strategies to improve bone and muscle strength after spinal cord injury. Dr. Forrest is assistant director of Human Performance & Engineering Research at Kessler Foundation.

18 Apr 2014

ARCA biopharma announces genetic screening of first patient in GENETIC-AF Phase 2B/3 clinical trial

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 adaptive design clinical trial.

From Medtronic 18 Apr 2014

April 21-27 officially proclaimed as Ann Arbor Veg Week

VegMichigan has teamed up with US VegWeek to bring you Ann Arbor Veg Week 2014, a week-long celebration of meat-free living.

18 Apr 2014

Adrenaline does not boost long-term survival rates in heart attack patients, says study

Giving patients adrenaline after they suffer a cardiac arrest outside of a hospital does not increase their prospects of surviving long-term, according to new research conducted at St. Michael's Hospital.

18 Apr 2014

Research provides fresh insight into structure of sodium channels

Sodium channels are implicated in many serious conditions such as heart disease, epilepsy and pain, making them an important potential target for drug therapies. Unfortunately, there is still much scientists do not know about the molecules.

18 Apr 2014

Docs who treat patients with severe LAM face agonizing treatment decision

Doctors who treat patients with a severe and progressive respiratory disease called lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision.

18 Apr 2014

SCRA Technology Ventures announces sale of Selah Genomics to EKF Diagnostics

SCRA Technology Ventures today announced that portfolio company Selah Genomics was sold to EKF Diagnostics, a publically-traded UK-based diagnostics firm.

From EKF Diagnostics 17 Apr 2014

iGetBetter joins Massachusetts Hospital Association to reduce hospital readmissions

iGetBetter, a supplier of post-acute care transition solutions designed to help reduce hospital readmissions, and the Massachusetts Hospital Association (MHA), the primary representative of the hospital community in the commonwealth, announced today that iGetBetter will join MHA and contribute to efforts now underway by Massachusetts hospitals to improve post-discharge care transition and reduce hospital readmissions.

17 Apr 2014

First Edition: April 17, 2014

Today's headlines include reports about emerging political strategies related to the health law and the upcoming congressional elections.

17 Apr 2014

Heart Disease News and Research

Latest Heart Disease News and Research

Synageva announces publication of LAL Deficiency review in Atherosclerosis

MEDNAX acquires Fredericksburg Anesthesia Associates

First Edition: April 21, 2014

Scientists lay groundwork for understanding immune responses in Lyme disease patients

Highly advanced imaging method helps to monitor rapid changes in glutathione redox potentials in live cells

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Research roundup: Colonscopy in the countryside; retiree health benefits; what should hip surgery cost?

Researchers receive $3.7M NIH grant to develop anti-smoking program for HIV-infected smoker

Researchers reveal connection between Down syndrome and acute lymphoblastic leukemia

Longer Looks: HIV epidemic in the Deep South; planning for Alzheimer's; Obamacare conspiracy theory

Le Bonheur Children's takes aggressive steps to minimize blood loss during heart surgery

Scientist receives $1.8M defense grant from Kessler Foundation for spinal cord injury research

ARCA biopharma announces genetic screening of first patient in GENETIC-AF Phase 2B/3 clinical trial

April 21-27 officially proclaimed as Ann Arbor Veg Week

Adrenaline does not boost long-term survival rates in heart attack patients, says study

Research provides fresh insight into structure of sodium channels

Docs who treat patients with severe LAM face agonizing treatment decision

SCRA Technology Ventures announces sale of Selah Genomics to EKF Diagnostics

iGetBetter joins Massachusetts Hospital Association to reduce hospital readmissions

First Edition: April 17, 2014

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Heart Disease News and Research

Latest Heart Disease News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in